Duplicate_Dermatology Research Institute Inc. /ID# 226172

Calgary, Alberta T2J 7E1

0 studies enrolling now · 1 studies all time

What they study most

Psoriasis

Studies at this site

• A Study of Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disease Symptoms — Completed